RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 88 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,231,280 | -3.1% | 53,709 | -30.3% | 0.00% | – |
| Q2 2023 | $1,271,279 | +40.3% | 77,094 | +51.8% | 0.00% | – |
| Q1 2023 | $906,325 | +361.6% | 50,803 | +653.4% | 0.00% | – |
| Q4 2022 | $196,356 | +263.6% | 6,743 | +210.2% | 0.00% | – |
| Q3 2022 | $54,000 | +45.9% | 2,174 | -75.6% | 0.00% | – |
| Q2 2022 | $37,000 | -67.3% | 8,928 | -9.1% | 0.00% | – |
| Q1 2022 | $113,000 | -46.2% | 9,818 | -53.6% | 0.00% | – |
| Q4 2021 | $210,000 | +624.1% | 21,143 | +855.4% | 0.00% | – |
| Q3 2021 | $29,000 | -84.8% | 2,213 | -77.4% | 0.00% | – |
| Q2 2021 | $191,000 | -57.4% | 9,771 | -53.6% | 0.00% | – |
| Q1 2021 | $448,000 | -51.8% | 21,063 | -32.7% | 0.00% | – |
| Q4 2020 | $930,000 | +152.0% | 31,281 | +83.7% | 0.00% | – |
| Q3 2020 | $369,000 | -23.1% | 17,025 | -20.8% | 0.00% | – |
| Q2 2020 | $480,000 | +109.6% | 21,506 | +43.2% | 0.00% | – |
| Q1 2020 | $229,000 | -57.2% | 15,014 | -35.6% | 0.00% | – |
| Q4 2019 | $535,000 | +119.3% | 23,306 | +106.3% | 0.00% | – |
| Q3 2019 | $244,000 | +64.9% | 11,296 | +67.7% | 0.00% | – |
| Q2 2019 | $148,000 | -34.5% | 6,735 | -18.5% | 0.00% | – |
| Q1 2019 | $226,000 | +10.2% | 8,262 | +8.2% | 0.00% | – |
| Q4 2018 | $205,000 | +25.8% | 7,636 | +36.6% | 0.00% | – |
| Q3 2018 | $163,000 | +8.7% | 5,589 | +16.4% | 0.00% | – |
| Q2 2018 | $150,000 | +63.0% | 4,800 | +4.3% | 0.00% | – |
| Q1 2018 | $92,000 | -29.8% | 4,601 | +1.9% | 0.00% | – |
| Q4 2017 | $131,000 | – | 4,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |